Amgen (NQ:<a title="Quote for Amgen" href="https://business.thepilotnews.com/thepilotnews/quote?Symbol=NQ%3AAMGN">AMGN )

EQNX::TICKER_START (NASDAQ:LEXX),(NASDAQ:AMGN),(NYSE:LLY),(OTCQX:RHHBY),(NASDAQ:WW) EQNX::TICKER_END

GLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons

January 10, 2024

With the bullish news flow lately, the market has taken a liking to health care stocks in recent weeks - including these three early 2024 gainers.

3 health care stocks off to strong starts in 2024

January 10, 2024

Topics Artificial Intelligence

Amgen Inc. (NASDAQ: AMGN) Records 52-Week High Tuesday Morning

January 02, 2024

Amgen Inc. (NASDAQ: AMGN) is a Leading Gainer in Tuesday Morning Trading

August 15, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:AMGN),(NASDAQ:AMAM),(NASDAQ:ELEV),(NASDAQ:NKTX) EQNX::TICKER_END

Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030

January 09, 2024

The iShares Biotechnology ETF (NASDAQ: IBB) emerged as a standout star, closing the first day of the year with a solid upswing of nearly 4%.

Will the Biotech sector sustain its momentum in 2024?

January 04, 2024

The Dow Jones Industrial Average is struggling in correction territory, but savvy investors keep an eye on resilient stocks like Microsoft, Amgen, and Walmart.

Topics ETFs

5 Dow stocks to track during the market correction

November 01, 2023

Topics ETFs Stocks

Amgen Inc. (NASDAQ: AMGN) is a Leading Gainer in Tuesday Morning Trading

August 08, 2023

Mind Science Targeting Big Brains and Portfolios

August 02, 2023

Via AB Newswire

Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030

January 09, 2024

From FN Media Group LLC

Via GlobeNewswire

Get Ready for Next Generation of Diabetes, Weight-Management Drugs

November 01, 2023

EQNX::TICKER_START (NASDAQ:LEXX),(NYSE:JNJ),(NYSE:SNY),(NASDAQ:AMGN),(NYSE:NVS) EQNX::TICKER_END

Get Ready for Next Generation of Diabetes, Weight-Management Drugs

November 01, 2023

The healthcare sector faces a selloff as pharmaceutical giants report lackluster earnings; even Amgen's strong results failed to prevent selling in the sector

Investor patience tested as pharmaceutical stocks take a tumble

November 01, 2023

EQNX::TICKER_START (OTCPK:DTCFF),(CSE:DTC),(NASDAQ:JAZZ),(NASDAQ:EXEL),(NASDAQ:AMGN),(NASDAQ:REGN) EQNX::TICKER_END

Global Cancer Vaccines Market Share Is Expected To Reach $19.27 Billion By 2030

October 25, 2023

These three equally-weighted exchange traded funds that offer superior diversification and risk adjusted returns are worth a look.

Why These 3 Equal-Weighted ETFs Deserve a Portfolio Spot

October 19, 2023

During the peak of the recent selloff, the healthcare sector outshone, with three stocks showing resilience and impressive upward moves.

Topics ETFs

Prescriptions for Portfolio Health: 3 Resilient Healthcare Stocks

October 12, 2023

Argenx's chart is forming a bullish base after a 28% jump after positive clinical trials. Analysts believe the immunology specialist is an acquisition target.

Topics ETFs

Argenx's 28% Surge & Promising Product Propel Investor Confidence

September 25, 2023

Revolutionary Cancer Treatment Advances Promise Brighter Future Amid Federal Funding Uncertainty

September 22, 2023

FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 22, 2023 – USA News Group – Despite the potential federal funding challenges due to the recent debt ceiling deal,...

In uncertain economic conditions, healthcare stocks can be a refuge due to steady demand and favorable inflation conditions. Many also offer dividends.

Flee to Healthcare Stocks if Recession Rears its Head?

September 20, 2023

As the calendar turns to September, optimistic investors will look for value in quality companies with a history of generating strong revenue and earnings

Topics Economy

3 Growth Stocks to Buy in September

September 06, 2023

Amgen and Horizon Therapeutics plc Resolve FTC Lawsuit, Clearing Path to Close Acquisition

Topics Economy

September 01, 2023

From Horizon Therapeutics plc and Amgen

Via Business Wire

How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?

September 01, 2023

Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects.

A handful of large caps have taken things to another level. These three stocks have blown past the herd — and may be market leaders for years to come.

Topics Economy

Drinks, Chips & Drugs: A Surprising List of 10-Year Stock Winners

August 11, 2023

Longeveron Announces Key Additions To Its Leadership Team and Board As It Gears Up For Phase 2 Trials For Its Lead Drug Candidate For Several Conditions

Topics Bankruptcy Economy

August 08, 2023

By David Willey, Benzinga

Via TheNewswire.com

Is Growth Priced into Amgen Stock after Earnings Beat?

August 07, 2023

Amgen earnings delivered a solid earnings report after the market closed but analyst sentiment suggests that growth may already be priced into AMGN stock.

INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Amgen Inc’s Directors and Officers for Breach of Fiduciary Duties – AMGN

July 27, 2023

From Scott+Scott Attorneys at Law LLP

Via Business Wire

Lilly Shares Up On Versanis Deal Amid Weight-Loss Drug Gold Rush

July 24, 2023

A bid to acquire Versanis boosts Eli Lilly & Co. by 2.80% in the past week, as the competition to develop the most effective weight-loss drug intensifies.

Regulatory filings show Gilead Sciences' purchase of shares in AlloVir and Arcus. Strategic investments in the biotech sector are fairly common to boost growth.

Gilead Boosts Biotech Footprint With Stakes In AlloVir And Arcus

July 13, 2023

Following a federal judge's OK of Microsoft's acquisition, Activision shares soared 10%, marking their strongest performance in over a year. The FTC can appeal.

Topics Retirement

Activision Surges 10% As Judge OK's Microsoft Acquisition Deal

July 12, 2023